Asymptomatic Bordetella pertussis infections in a longitudinal cohort of young African infants and their mothers
Recent pertussis resurgence in numerous countries may be driven by asymptomatic infections. Most pertussis surveillance studies are cross-sectional and cannot distinguish asymptomatic from pre-symptomatic infections. Longitudinal surveillance could overcome this barrier, providing more information about the true burden of pertussis at the population level. Here we analyze 17,442 nasopharyngeal samples from a longitudinal cohort of 1320 Zambian mother/infant pairs. Our analysis has two elements. First, we demonstrate that the full range of IS481 qPCR CT values provides insight into pertussis epidemiology, showing concordance of low and high CT results over time, within mother/infant pairs, and in relation to symptomatology. Second, we exploit these full-range qPCR data to demonstrate a high incidence of asymptomatic pertussis, including among infants. Our results demonstrate a wider burden of pertussis infection than we anticipated in this population, and expose key limitations of threshold-based interpretation of qPCR results in infectious disease surveillance..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
eLife - 10(2021) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Christopher J Gill [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Africa |
|---|
| doi: |
10.7554/eLife.65663 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ03221829X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ03221829X | ||
| 003 | DE-627 | ||
| 005 | 20230307165053.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7554/eLife.65663 |2 doi | |
| 035 | |a (DE-627)DOAJ03221829X | ||
| 035 | |a (DE-599)DOAJ6086895b132143988fae5aa8f1a946aa | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a QH301-705.5 | |
| 100 | 0 | |a Christopher J Gill |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Asymptomatic Bordetella pertussis infections in a longitudinal cohort of young African infants and their mothers |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Recent pertussis resurgence in numerous countries may be driven by asymptomatic infections. Most pertussis surveillance studies are cross-sectional and cannot distinguish asymptomatic from pre-symptomatic infections. Longitudinal surveillance could overcome this barrier, providing more information about the true burden of pertussis at the population level. Here we analyze 17,442 nasopharyngeal samples from a longitudinal cohort of 1320 Zambian mother/infant pairs. Our analysis has two elements. First, we demonstrate that the full range of IS481 qPCR CT values provides insight into pertussis epidemiology, showing concordance of low and high CT results over time, within mother/infant pairs, and in relation to symptomatology. Second, we exploit these full-range qPCR data to demonstrate a high incidence of asymptomatic pertussis, including among infants. Our results demonstrate a wider burden of pertussis infection than we anticipated in this population, and expose key limitations of threshold-based interpretation of qPCR results in infectious disease surveillance. | ||
| 650 | 4 | |a Bordetella pertussis | |
| 650 | 4 | |a whooping cough | |
| 650 | 4 | |a cohort study | |
| 650 | 4 | |a asymptomatic infection | |
| 650 | 4 | |a qPCR | |
| 650 | 4 | |a Africa | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Science | |
| 653 | 0 | |a Q | |
| 653 | 0 | |a Biology (General) | |
| 700 | 0 | |a Christian E Gunning |e verfasserin |4 aut | |
| 700 | 0 | |a William B MacLeod |e verfasserin |4 aut | |
| 700 | 0 | |a Lawrence Mwananyanda |e verfasserin |4 aut | |
| 700 | 0 | |a Donald M Thea |e verfasserin |4 aut | |
| 700 | 0 | |a Rachel C Pieciak |e verfasserin |4 aut | |
| 700 | 0 | |a Geoffrey Kwenda |e verfasserin |4 aut | |
| 700 | 0 | |a Zacharia Mupila |e verfasserin |4 aut | |
| 700 | 0 | |a Pejman Rohani |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t eLife |d eLife Sciences Publications Ltd, 2013 |g 10(2021) |w (DE-627)DOAJ000080845 |x 2050084X |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |
| 856 | 4 | 0 | |u https://doi.org/10.7554/eLife.65663 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/6086895b132143988fae5aa8f1a946aa |z kostenfrei |
| 856 | 4 | 0 | |u https://elifesciences.org/articles/65663 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2050-084X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 | ||